科学进步及密集的研究与开发使人们研制出许多新型口服抗丙肝病毒感染的药物。
Scientific advances and intense research and development have led to the development of many new oral antiviral drugs for HCV infection.
目的查明丙肝病毒抗体（抗- HCV）在无偿献血人群中的分布及流行趋势，帮助血站选择理想的献血人群。
Objective To understand the distribution and epidemiological trend of Anti-HCV in blood donors and to select ideal blood donation population.
麦考酚酸表现出一种特殊的抗丙肝病毒复制的作用机制，它不依赖细胞增殖及鸟嘌呤核苷消耗。
MPA was shown to hae a distinct anti-HC mechanism of action, independent of cell proliferation and guanosine depletion.
应用推荐